Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis

被引:52
作者
Moro-Sibilot, D. [1 ]
Lantuejoul, S. [1 ,3 ]
Diab, S.
Moulai, N. [3 ]
Aubert, A. [1 ,2 ]
Timsit, J. F. [1 ]
Brambilla, C. [1 ]
Brichon, P. Y. [1 ,2 ]
Brambilla, E. [1 ,3 ]
机构
[1] Inst A Bonniot, INSERM, Lung Canc Res Grp, La Tronche, France
[2] Hop Albert Michalon, Dept Chirurg Thorac Cardiovasc & Endocrinienne, F-38043 Grenoble 9, France
[3] Hop Albert Michalon, Dept Anat & Cytol Pathol, F-38043 Grenoble 9, France
关键词
basaloid carcinoma; diagnosis and staging; lung cancer; pathology;
D O I
10.1183/09031936.00058507
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Lung carcinoma with a basaloid pattern (BC) is classified as either a basaloid variant of squamous cell carcinoma (SCC) or as variant of large cell carcinoma (LCC) depending on the presence of a squamous component. In a previous study of 37 cases, the present authors showed that BC presented with a shorter median and overall survival. In order to confirm its clinical significance in a larger series, 90 BC, including 46 basaloid variants of LCC and 44 basaloid variants of SCC, were compared with 1,328 other nonsmall cell lung carcinoma (NSCLC) with regard to clinical features and survival. The survival of basaloid variants of LCC and SCC was comparable. Median and overall survival were significantly lower for BC than for NSCLC in stage I-II patients, with a median survival of 29 and 49 months, respectively, and 5-yr survival rates of 27 and 44% for BC and NSCLC. When disease-specific survival was considered, BC had a shorter survival than both NSCLC and SCC. Basaloid pattern confers a poor prognosis in nonsmall cell lung carcinoma, especially in stage I-II patients, suggesting that lung carcinoma with a basaloid pattern is not only a variant of squamous cell carcinoma or large cell carcinoma, but is a unique entity with a significantly poor prognosis.
引用
收藏
页码:854 / 859
页数:6
相关论文
共 27 条
[1]   Basaloid squamous cell carcinoma versus basal cell adenocarcinoma of the oral cavity [J].
Andreadis, D ;
Nomikos, A ;
Epivatianos, A ;
Poulopoulos, A ;
Barbatis, C .
PATHOLOGY, 2005, 37 (06) :560-U11
[2]   BASAL-CELL (BASALOID) CARCINOMA OF THE LUNG - A NEW MORPHOLOGICAL AND PHENOTYPIC ENTITY WITH SEPARATE PROGNOSTIC-SIGNIFICANCE [J].
BRAMBILLA, E ;
MORO, D ;
VEALE, D ;
BRICHON, PY ;
STOEBNER, P ;
PARAMELLE, B ;
BRAMBILLA, C .
HUMAN PATHOLOGY, 1992, 23 (09) :993-1003
[3]  
BRAMBILLA E, 1998, LUNG TUMORS FUNDAMEN, P55
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].
Douillard, Jean-Yves ;
Rosell, Rafael ;
De Lena, Mario ;
Carpagnano, Francesco ;
Ramlau, Rodryg ;
Gonzales-Larriba, Jose Luis ;
Grodzki, Tornasz ;
Pereira, Jose Rodrigues ;
Le Groumellec, Alain ;
Lorusso, Vito ;
Clary, Claude ;
Torres, Antonio J. ;
Dahabreh, Jabrail ;
Souquet, Pierre-Jean ;
Astudillo, Julio ;
Fournel, Pierre ;
Artal-Cortes, Angel ;
Jassem, Jacek ;
Koubkova, Leona ;
His, Patricia ;
Riggi, Marcella ;
Hurteloup, Patrick .
LANCET ONCOLOGY, 2006, 7 (09) :719-727
[6]   Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer:: The international adjuvant lung cancer trial biologic program [J].
Filipits, Martin ;
Pirker, Robert ;
Dunant, Ariane ;
Lantuejoul, Sylvie ;
Schmid, Katharina ;
Huynh, Anh ;
Haddad, Vincent ;
Andre, Fabrice ;
Stahel, Rolf ;
Pignon, Jean-Pierre ;
Soria, Jean-Charles ;
Popper, Helmut H. ;
Le Chevalier, Thierry ;
Brambilla, Elisabeth .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) :2735-2740
[7]   Basaloid carcinoma of the thymus [J].
Kawashima, O ;
Kamiyoshihara, M ;
Sakata, S ;
Kurihara, T ;
Ishikawa, S ;
Morishita, Y .
ANNALS OF THORACIC SURGERY, 1999, 68 (05) :1863-1865
[8]   Basaloid carcinoma of the lung: A really dismal histologic variant? [J].
Kim, DJ ;
Kim, KD ;
Shin, DH ;
Ro, JY ;
Chung, KY .
ANNALS OF THORACIC SURGERY, 2003, 76 (06) :1833-1837
[9]   Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].
Le Chevalier, T ;
Arriagada, R ;
Le Péchoux, C ;
Grunenwald, D ;
Dunant, A ;
Pignon, JP ;
Tarayre, M ;
Abratt, R ;
Arriagada, R ;
Bergman, B ;
Gralla, R ;
Grunenwald, D ;
Le Chevalier, T ;
Orlowski, T ;
Papadakis, E ;
Pinel, MIS ;
Araujo, C ;
Della Torre, H ;
de Solchaga, MM ;
Abdi, E ;
Blum, R ;
Ball, D ;
Basser, R ;
De Boer, R ;
Bishop, J ;
Brigham, B ;
Davis, S ;
Fox, D ;
Richardson, G ;
Wyld, D ;
Pirker, R ;
Humblet, Y ;
Delaunois, L ;
Van Meerbeeck, JP ;
Germonpre, P ;
Vansteenkiste, J ;
Nackaerts, K ;
Pinel, MIS ;
Vauthier, G ;
Younes, RN ;
Arriagada, R ;
Baeza, R ;
Carvajal, P ;
Kleinman, S ;
Orlandi, L ;
Castro, C ;
Godoy, J ;
Kosatova, K ;
Gaafar, R ;
Azarian, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360
[10]  
MORO D, 1994, CANCER-AM CANCER SOC, V73, P2734, DOI 10.1002/1097-0142(19940601)73:11<2734::AID-CNCR2820731114>3.0.CO